Although extensive studies have investigated PD-L1 ubiquitination in cancer, its regulatory mechanisms in pancreatic cancer remain to be systematically elucidated—with critical gaps in understanding the interplay between ubiquitination, phosphorylation, and autophagic degradation in shaping PD-L1 expression and immunotherapy responses. Here, CD274 is linked to cancer.